How Is the Effectiveness of Immune Checkpoint Inhibitors Measured?
The effectiveness of immune checkpoint inhibitors is usually measured through clinical trials using various endpoints such as overall survival, progression-free survival, and response rates. Biomarkers, such as PD-L1 expression levels, can sometimes help predict which patients are more likely to benefit from these therapies.
